Company / Cash & Equivalents
Amn Healthcare Services, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$34.0M
FY2025
5-year range
$10.6M / $180.9M
FY2021-FY2025
Trend
+219.0%
vs FY2024
Sector context
#143 of 152
Health Care
What the data says
Cash & Equivalents changed +219% YoY in FY2025, a notable deviation from the 9-year average annual change of +114%.
Based on SEC 10-K filings.
$34M in FY2025 with a 5-year CAGR of +3.1%.
Improved from $33M to $34M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -19.3%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 152This company $34.0M Sector average $1.2B
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.1%, indicating consistent growth.
- In FY2025, cash & equivalents increased 219.0% year-over-year.
- Ranks #143 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.0M | +219.0% |
| FY2024 | $10.6M | -67.7% |
| FY2023 | $32.9M | -49.0% |
| FY2022 | $64.5M | -64.3% |
| FY2021 | $180.9M | +519.3% |
| FY2020 | $29.2M | -64.8% |
| FY2019 | $83.0M | +498.9% |
| FY2018 | $13.9M | -8.5% |
| FY2017 | $15.1M | +42.6% |
| FY2016 | $10.6M | +10.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026